GeneNews appoints Dr Roman Zastawny VP Biomarker Development
16th Nov 2006, 08:21 GMT
GeneNews, formerly ChondroGene announced that Dr Roman L Zastawny has been appointed VP of Biomarker Development.
GeneNews appoints Dr Roman Zastawny VP Biomarker Development related news:
- Tacere Therapeutics Appoints VP, R&D — Pharmaceuticals News from StratCenter.com
- Diffusion Pharmaceuticals Strengthens Mgmt Team With Appointment of Matthew W Hantzmon as VP, Business Development — Government/ Industry Regulation News from StratCenter.com
- Zones, Inc.: Zones Appoints Thomas Lutz as VP Business Development — Market Wire - Computers and Software
- Newly Identified Biomarker Detects And Regulates Spread Of Brain Tumors — ScienceDaily Headlines
- Kendle Appoints Sylva H Collins, PhD, as VP, Global Biometrics — Information Technologies/ MIS/ HIS News from StratCenter.com
- Anika Therapeutics Appoints Constance Garrison as VP of Regulatory and Clinical Affairs — Executive Announcements News from StratCenter.com
- LAWA Appoints David Shuter as the New Deputy Executive Director of Project and Facilities Development Services — ArriveNet : Travel
- Los Angeles World Airports: LAWA Appoints David Shuter as the New Deputy Executive Director of Project and Facilities Development Services — Market Wire - Transportation and Logistics
- Tacere Therapeutics Appoints Vice President, Research and Development — RedOrbit News - Health
- Roman Shipwreck Dazzles Scientists — World News: CBSnews.com
Latest news from FDA News News from StratCenter.com:
- North American Gets Cancer Treatment OK
- North American Scientific Announces FDA Clearance of its ClearPath HDR Breast Brachytherapy System
- Newly FDA Approved SmartLipo Laser Liposuction Available at the Intimate Rejuvenation and Innovative Surgery Center, Phoenix, AZ.
- ACT-AD Coalition Calls FDA's New Focus on Neurological Diseases a Positive 1st Step
- Ivax Diagnostics Delays Filing 3Q Report
- New Corporate Members and Leaders for C-Path's Predictive Safety Testing Consortium Announced
- Diagnosoft Receives FDA Approval for Cardiac MRI Quantitative Regional Function Software Based on the HARP Technology
- PAREXEL Consulting Expands Risk Mgmt Expertise, Appoints Former FDA Consumer Safety Officer Raymond T Oji as Senior Consultant
- Trubion Pharmaceuticals to Present at the Lazard Life Sciences Conference
- Critical Therapeutics Announces Efficacy Data for Controlled-Release Formulation of Zileuton Presented at ACAAI 2006 Annual Meeting